Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSA and benign prostatic hyperplasia].

J Grall1, L Corbel

  • 1Cabinet médical, 3, place de la République, 21000 Dijon, France. j-s.grall@wanadoo.fr

Annales D'Urologie
|January 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

[De novo or secondary metastatic prostate cancer management in France: Observational study from "sentinel multidisciplinary meeting" of the French Association of Urology].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Artificial urinary sphincter in patients with urinary incontinence after High Intensity Focused ultrasound].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Radical prostatectomy for prostate cancer, perioperative management by French urologists in 2018].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same journal

Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.

Annales d'urologie·2008
Same journal

[Surgical treatment of ureteropyelic junction stenosis using robotic-assisted laparoscopy].

Annales d'urologie·2008
Same journal

[Robotic-assisted laparoscopy: general principles].

Annales d'urologie·2008
Same journal

[De novo tumours of renal transplants].

Annales d'urologie·2008
Same journal

[Immunosuppression in kidney transplantation].

Annales d'urologie·2008
Same journal

[Surgical complications in kidney transplantation].

Annales d'urologie·2008
See all related articles

Prostate-specific antigen (PSA) screening, commonly used for prostate cancer, may also aid in managing benign prostatic hyperplasia (BPH). Further research is needed to establish guidelines for its use in BPH care.

Area of Science:

  • Urology
  • Andrology
  • Biochemistry

Context:

  • Prostate-specific antigen (PSA) is primarily used for prostate cancer screening.
  • Current urological practice often excludes PSA from benign prostatic hyperplasia (BPH) diagnosis and management.
  • PSA values are readily available for many men over 50 due to prostate cancer screening protocols.

Purpose:

  • To explore the potential role of PSA in understanding and managing the natural history of benign prostatic hyperplasia (BPH).
  • To investigate whether PSA can be utilized as a tool for BPH management and prevention of complications like urinary retention.
  • To highlight the emerging evidence linking PSA levels to BPH progression.

Summary:

  • While not specific for any single disease, PSA levels correlate with the natural history of BPH.

Related Experiment Videos

  • PSA screening, already common for prostate cancer, could offer insights into BPH.
  • Emerging data suggest PSA may help manage BPH and prevent complications such as retention.

    • Impact:

    • Establishes a potential new application for readily available PSA data in urological care.
    • Suggests a paradigm shift in how PSA is viewed, extending its utility beyond cancer detection.
    • Highlights the need for developing clinical guidelines to integrate PSA into BPH management strategies.